Importance Hyperprogressive disease (HPD) is a recognized pattern of rapid tumor
progression during immune checkpoint inhibitor (ICI) treatment. Definitions of HPD have not …

This study presents a comprehensive systematic review focusing on the applications of deep
learning techniques in lung cancer radiomics. Through a rigorous screening process of 589 …

Lung cancer, with non-small cell lung cancer (NSCLC) being the major type, is the second
most common malignancy and the leading cause of cancer-related death globally …

Simple Summary Immune checkpoint inhibitors (ICIs) and radiotherapy (RT) are widely used
for patients with brain metastasis (BM). To evaluate markers for treatment response and find …

Immunotherapy has revolutionized and opened a new paradigm for cancer treatment. In the
era of immunotherapy and molecular targeted therapy, precision medicine has gained …

Simple Summary It is controversial whether iRECIST has a significant impact over RECIST
1.1 in evaluating the efficacy of immune checkpoint inhibitor treatment. We aimed to …

Background Immunotherapy, particularly the utilization of immune checkpoint inhibitors
(ICIs), assumes a pivotal role in the comprehensive management of advanced lung cancer …

Background Harnessing the anti-tumor immune system response by targeting the program
cell death protein (PD-1) and program cell death ligand protein (PD-L1) axis has been a …

Background: Rechallenge of immunotherapy beyond progression (RIBP) has been
demonstrably effective in a variety of cancers. Our study aims to investigate the efficacy of …

Immunotherapy (ITH) holds the possibility of tumor burden decrease after initial RECIST 1.1
defined progression. The clinical concept of treating selected patients (pts) beyond disease …